Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

An experimental treatment that stimulates the spinal cord may help people with a paralyzing genetic disorder called spinal muscular atrophy.

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Researchers have shown that a spinal cord-stimulating implant, originally used for paralysis, may help restore muscle ...

A new spinal cord implant may help people with spinal muscular atrophy (SMA) regain some muscle function, giving them ...

How a tiny spinal implant could help those with muscle-wasting disease - Three people with a muscle-destroying disease got ...

Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.

Currently, no drug treatment for muscle wasting is available ... hampered motor function and skeletal muscle atrophy (Bennett and Xie, 1988). Even though nerve function may recover, this is often ...

Background: Spinal and bulbar muscular atrophy (SBMA) or Kennedy disease [OMIM ... correct and timely diagnosis could also help in providing timely treatment for patients. The original contributions ...

Novartis' gene therapy portfolio includes spinal muscular atrophy treatment Zolgensma (onasemnogene abeparvovec) – used to treat upwards of 3,400 patients worldwide with third-quarter sales of $ ...